Platt David

Avg. Two Year Performance

(< 1%) Avg. Purchase Return
0% Compound
90% Avg. Sale Return
38% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(9%)(12%)(23%)(23%)(< 1%)
Purchase Success Rate2 of 62 of 61 of 62 of 61 of 6
Average Sale Return29%78%87%77%90%
Sale Success Rate1 of 11 of 11 of 11 of 11 of 1
Drugs » Drugs - Generic

Chairman & CEO, Director:

Holdings: 6.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

CEO, Director, 10% Owner:

Holdings: 22.77M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

CEO and Chairman, Director, 10% Owner:

Holdings: 7.56M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

:

Holdings: 709.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--